Integra Lifesciences Holdings Corp

-2.56 (-4.11%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.97B
Current PE31.73
Forward PE 18
2yr Forward PE 16.33
See more stats
Estimates Current Quarter
Revenue$395.8 Million
Adjusted EPS$0.80
See more estimates
10-Day MA$59.75
50-Day MA$62.75
200-Day MA$66.93
See more pivots

Integra Lifesciences Holdings Corp Stock, NASDAQ:IART

1100 Campus Road, Princeton, New Jersey 08540
United States of America
Phone: +1.609.275.0500
Number of Employees: 3800


Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care, such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment, and the precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.